Cargando…

Immune Landscape of the Tumor Microenvironment Identifies Prognostic Gene Signature CD4/CD68/CSF1R in Osteosarcoma

Background: Osteosarcoma (OSA), the most common primary bone malignancy in children and adolescents, is prone to metastases and unfavorable prognosis. Owing to its strong genomic heterogeneity, traditional chemotherapy, or targeted immunotherapy has not effectively improved the related overall survi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Yi-jiang, Xu, Yanyang, Zhu, Xiaojun, Fu, Jianchang, Deng, Chuangzhong, Chen, Hongmin, Xu, Huaiyuan, Song, Guohui, Lu, Jinchang, Tang, Qinglian, Wang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396617/ https://www.ncbi.nlm.nih.gov/pubmed/32850346 http://dx.doi.org/10.3389/fonc.2020.01198

Ejemplares similares

Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes
por: Song, Yi-Jiang, et al.
Publicado: (2021)

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
por: Deng, Chuangzhong, et al.
Publicado: (2020)

Comprehensive analysis of immune infiltration and gene expression for predicting survival in patients with sarcomas
por: Chen, Hongmin, et al.
Publicado: (2020)

Minimally invasive separation surgery for the treatment of spinal metastases with small incision and freehand pedicle screw fixation: the surgical learning curve
por: Lin, Jiaming, et al.
Publicado: (2022)

Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma
por: Xu, HuaiYuan, et al.
Publicado: (2022)

Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2012)

A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma
por: Zhang, Lina, et al.
Publicado: (2022)

A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma
por: Wang, Xinxing, et al.
Publicado: (2022)

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma
por: Kong, Ling-Qun, et al.
Publicado: (2013)

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
por: Bravaccini, Sara, et al.
Publicado: (2019)

Fibrolamellar Carcinomas are Positive for CD68
por: Ross, Hillary M, et al.
Publicado: (2010)

G‐CSF induces CD15(+) CD14(+) cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironment
por: Maneta, Ebtehag, et al.
Publicado: (2022)

Enrichment of Murine CD68(+)CCR2(+) and CD68(+)CD206(+) Lung Macrophages in Acute Pancreatitis-Associated Acute Lung Injury
por: Akbarshahi, Hamid, et al.
Publicado: (2012)

Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer
por: Dimitrova, Polina, et al.
Publicado: (2023)

MYC inhibition reprograms tumor immune microenvironment by recruiting T lymphocytes and activating the CD40/CD40L system in osteosarcoma
por: Jiang, Kuo, et al.
Publicado: (2022)

Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
por: Zhang, Wenshuo, et al.
Publicado: (2022)

High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis
por: Li, Philippa, et al.
Publicado: (2021)

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
por: Zhang, Jun-Song, et al.
Publicado: (2023)

CD206(+)CD68(+) mono-macrophages and serum soluble CD206 level are increased in antineutrophil cytoplasmic antibodies associated glomerulonephritis
por: An, Xiao-Ning, et al.
Publicado: (2022)

Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity
por: Wang, Hongsheng, et al.
Publicado: (2022)

CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma
por: Harris, Jonathan A, et al.
Publicado: (2012)

Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
por: Ren, Chun-Xia, et al.
Publicado: (2017)

The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma
por: Salmi, Satu, et al.
Publicado: (2019)

Correlation between CD 34 and CD 68 expression in placental malaria with maternal anemia
por: Rustamadji, Primariadewi, et al.
Publicado: (2021)

Prophylaxis of decidual CD68(+)/CD163(+) macrophage disbalance in extracorporeal fertilized women
por: Likhachov, Volodymyr, et al.
Publicado: (2023)

PD-1(+)CD8(+) T Cells Proximal to PD-L1(+)CD68(+) Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients
por: Yang, Xiaobao, et al.
Publicado: (2023)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022)

CD4+CD56+CD68+hematopoietic tumor of probable plasmacytoid monocyte derivation with weak expression of cytoplasmic CD3.
por: Ko, Young Hyeh, et al.
Publicado: (2002)

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers
por: Pelekanou, Vasiliki, et al.
Publicado: (2018)

Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape
por: Hong-bin, Shao, et al.
Publicado: (2022)

Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Zhou, Yan, et al.
Publicado: (2020)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Genetic Ablation of CD68 Results in Mice with Increased Bone and Dysfunctional Osteoclasts
por: Ashley, Jason W., et al.
Publicado: (2011)

Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
por: Feng, Xiaofei, et al.
Publicado: (2022)

Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma
por: Mavili, Hanife Seda, et al.
Publicado: (2021)

CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
por: Xu, Ji-Feng, et al.
Publicado: (2015)

Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma
por: Diana, Angela, et al.
Publicado: (2016)

Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma
por: Wu, Fengfeng, et al.
Publicado: (2022)

IRX1 hypomethylation in osteosarcoma metastasis
por: Lu, Jinchang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h2afe3oohmcaim8cderptdau3c